Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Polymyalgia Rheumatica: later-stage trial registry
2 of 3 indexed Polymyalgia Rheumatica trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Polymyalgia Rheumatica: 3 US clinical trials tracked, 2 recruiting.
Polymyalgia Rheumatica is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Lahey Clinic, running 1 of these trials.
Enrollment posture brief
Registry condition polymyalgia-rheumatica
OPEN 2 | RECR 67% | LATE 1 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Polymyalgia Rheumatica lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Polymyalgia Rheumatica on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Polymyalgia Rheumatica is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Novartis Pharmaceuticals
NCT06331312
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
M.D. Anderson Cancer Center
NCT06647134
Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica
Lahey Clinic
NCT00847236
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Polymyalgia Rheumatica records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Polymyalgia Rheumatica trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Polymyalgia Rheumatica page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Polymyalgia Rheumatica trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Lahey Clinic sponsors the most Polymyalgia Rheumatica trials on record, review their full trial history before evaluating a specific study. See Lahey Clinic's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Polymyalgia Rheumatica condition card totals 3 registered trials; most-linked intervention Secukinumab; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.